Dyne Therapeutics

We’re pleased to sponsor Team Joseph's first ever “What Now?” virtual conference. Learn more and register for this community event that focuses on older adolescents and adults with #Duchenne: https://bit.ly/3y5svX1

Our #Dynamos gathered for our third annual FORCE for Good Service Day, dedicating the day to supporting local nonprofits in the #Boston area. Thank you to our wonderful partners at Life Science Cares Boston for the opportunity to make a positive impact and give back to our community! The Food Project Cradles to Crayons Massachusetts Community Servings STEAM Ahead MSPCA-Angell Mystic River Watershed Association

On July 12, we’re joining the Myotonic Dystrophy Foundation for a “Meet the DM Drug Developers” webinar. We will discuss the recent ACHIEVE clinical trial data for our investigational medicine, DYNE-101. Following the presentation, our Chief Medical Affairs Officer, Ash Dugar, will participate in a live Q&A. Don’t forget to register in advance to submit your questions! https://bit.ly/3WcJGPR #MyotonicDystrophy

Join us at the 4th Annual Oligonucleotides for CNS Summit. Catch our presentation about our proprietary FORCE™ Platform and hear about data demonstrating its ability to achieve delivery to muscle & the central nervous system (CNS): See the agenda: https://bit.ly/4cynFAF

We’re excited to join the DMD community for a webinar with Defeat Duchenne Canada on July 8. Register to learn about the clinical data from our DELIVER trial of DYNE-251, a potential therapeutic for people living with #DMD who are amenable to exon 51 skipping: https://bit.ly/3VEuR8i #Duchenne #patientadvocacy #clinicaltrial

On July 3rd, we’ll join CureDuchenne for a webinar about the efficacy and safety data from the DELIVER trial of DYNE-251, an investigational therapeutic for people with #DMD amenable to exon 51 skipping: https://bit.ly/3zvfpTf #clinicaltrial #drugdevelopment

We’re excited to join the #Duchenne community for the Parent Project Muscular Dystrophy's 2024 Annual Conference! Catch the presentation on clinical data from the DELIVER study on Friday, June 28th, during the “Research Row: Strategies to Restore Dystrophin Session.” Register here: https://bit.ly/3VZr3yE

Bright, motivated, driven, and energetic are just a few of the characteristics of a #Dynamo. Listen to our team describe the unique attributes of employees and visit our website to learn more about working at Dyne: https://bit.ly/3VSQPod #STEMcareers #biotechnology #innovation

Today we announced new preclinical data demonstrating the potential of the FORCE™ platform to deliver enzyme replacement therapy to muscle and CNS in Pompe disease. Read more: https://bit.ly/4bhbZkc

Our team recognized #WorldFSHDDay this year by joining with FSHD Society to increase awareness of one of the common symptoms of #FSHD – the inability to smile. Learn more about the day and share your own orange slice selfie smile: https://bit.ly/3xmOSXP